We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Extracellular Collagen Modulates Tumor Progression and Metastasis

By LabMedica International staff writers
Posted on 05 Dec 2017
A recent paper detailed how factors in the tumor microenvironment induce the cancer to progress and metastasize.

Previous studies had suggested that the topographical organization of collagen within the tumor microenvironment modulated cancer cell migration and was independently predictive of progression to metastasis.

Investigators at the University of California, San Diego (USA) explored the relationships between collagen density, collagen architecture, cell migration behavior, gene expression, and metastatic potential. More...
To do this, they developed a three-dimensional collagen matrix model system designed to probe the physical basis of cancer cell migration responses to collagen matrix organization.

Results published in the November 21, 2017, online edition of the journal Nature Communications revealed that collagen matrices with small pores and short fibers conserved a transcriptional response and subsequent motility switch in cancer cells resulting in the formation of multicellular network structures. The response was not mediated by hypoxia, matrix stiffness, or bulk matrix density, but rather by matrix architecture-induced beta1-integrin upregulation. The set of genes, or gene module, which caused this behavior, was dubbed the collagen-induced network phenotype (CINP).

The investigators found that this CINP-induced behavior was consistent with phenotypic and molecular features of clinical vasculogenic mimicry (VM) – the formation of structures resembling blood vessels. Furthermore, they showed that the associated transcriptional response was conserved among cancer types in vitro and was predictive of patient survival in multiple clinical datasets for various tumor types. These findings linked a collagen-induced migration program to VM and suggested that this process could be broadly relevant to metastatic progression in solid human cancers.

"It is almost like the matrix is encoding the gene module," explained senior author Dr. Stephanie Fraley, professor of bioengineering at the University of California, San Diego. "The cells do not exhibit this behavior in traditional petri dishes. It is critical to have the cells surrounded by a three-dimensional environment that mimics what happens in the human body."

Related Links:
University of California, San Diego


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated PCR Setup
ESTREAM
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.